Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
Annals of Surgical Oncology|July 11, 2013
Induction of a pathological complete response by four courses of neoadjuvant chemotherapy for gastric cancer: early results of the randomized phase II COMPASS trialTakaki Yoshikawa, Kazuaki Tanabe, Kazuhiro Nishikawa, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2018
Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC TrialHironori Ishigami, Yoshiyuki Fujiwara, Ryoji Fukushima, et al.Journal of Palliative Medicine|March 23, 2018
Factors Influencing Cancer Patients' Choice of End-of-Life Care PlaceMaika Natsume, Kiyotaka Watanabe, Satoko Matsumoto, et al.BMC Gastroenterology|September 2, 2024
Evaluation of pembrolizumab plus cisplatin and fluorouracil in radical treatment for patients with T4b esophageal squamous cell carcinomaNobukazu Hokamura, Takeo Fukagawa, Ryoji Fukushima, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|April 1, 2021
QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational studyYuichi Ito, Kazumasa Fujitani, Kentaro Sakamaki, et al.Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|October 14, 2011
Combination chemotherapy with S-1 plus cisplatin for gastric cancer that recurs after adjuvant chemotherapy with S-1: multi-institutional retrospective analysisKohei Shitara, Satoshi Morita, Kazumasa Fujitani, et al.Surgery Today|May 4, 2018
Effect of early oral feeding on length of hospital stay following gastrectomy for gastric cancer: a Japanese multicenter, randomized controlled trialNobuyuki Shimizu, Eiji Oki, Yutaka Tanizawa, et al.Journal of Cancer|May 29, 2018
The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C)Kazuhiro Nishikawa, Toru Aoyama, Mari S Oba, et al.Journal of Translational Medicine|July 11, 2012
Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigensKoji Kono, Hisae Iinuma, Yasunori Akutsu, et al.The Lancet. Oncology|June 24, 2014
Sequential paclitaxel followed by tegafur and uracil (UFT) or S-1 versus UFT or S-1 monotherapy as adjuvant chemotherapy for T4a/b gastric cancer (SAMIT): a phase 3 factorial randomised controlled trialAkira Tsuburaya, Kazuhiro Yoshida, Michiya Kobayashi, et al.Pageof 7